Atlas Venture Life Science Advisors, LLC Q1 2024 Filing
Filed May 6, 2024
Portfolio Value
$1.1T
Holdings
16
Report Date
Q1 2024
Filing Type
13F-HR
All Holdings (16 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | DYNDyne Therapeutics, Inc. | 8,020,136 | $227.7B | 21.01% | |
| 2 | KYMRKymera Therapeutics, Inc. | 5,377,362 | $216.2B | 19.95% | |
| 3 | IRONDisc Medicine, Inc. | 2,287,233 | $142.4B | 13.14% | |
| 4 | DAWNDay One Biopharmaceuticals, Inc. | 6,430,257 | $106.2B | 9.80% | |
| 5 | THRDThird Harmonic Bio, Inc. | 10,907,859 | $103.0B | 9.50% | |
| 6 | KRROKorro Bio, Inc. | 1,119,292 | $100.7B | 9.30% | |
| 7 | AVTEAerovate Therapeutics, Inc. | 2,039,249 | $60.3B | 5.57% | |
| 8 | QTTBQ32 Bio, Inc. | 2,092,106 | $35.6B | 3.29% | |
| 9 | GBIOGBXGeneration Bio, Co. | 8,279,484 | $33.7B | 3.11% | |
| 10 | VIGLVigil Neuroscience, Inc. | 5,836,874 | $19.9B | 1.84% | |
| 11 | REPLReplimune Group, Inc. | 2,098,300 | $17.1B | 1.58% | |
| 12 | —Ikena Oncology, Inc. | 5,018,178 | $7.1B | 0.66% | |
| 13 | —AvroBio, Inc. | 4,541,381 | $5.8B | 0.54% | |
| 14 | DNTHDianthus Therapeutics, Inc. | 186,979 | $5.6B | 0.52% | |
| 15 | XLOXilio Therapeutics, Inc. | 992,912 | $1.1B | 0.10% | |
| 16 | SPROSpero Therapeutics, Inc. | 607,613 | $1.0B | 0.10% |